Supplementary Figure 2: Pathway analysis in AD-MSCs and PSCs activated by Muc5ac
<p dir="ltr">Supplementary Figure 2: Pathway analysis in AD-MSCs and PSCs activated by Muc5ac. A, B) The top significantly down (A) and up (B) regulated GO pathways in AD-MSC in comparison with PSCs treated with Muc5ac-proficient (KCT3266) or deficient (KCT3266 Muc5ac KO) CM. C, D) T...
保存先:
| 第一著者: | Sushil Kumar (20371917) (author) |
|---|---|
| 出版事項: |
2025
|
| 主題: | |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
類似資料
-
Supplementary Figure 1: Activation of AD-MSCs and PSCs by Muc5ac
著者:: Sushil Kumar (20371917)
出版事項: (2025) -
Supplementary Figure 4: RNA-sequencing in the primary AD-MSCs, BM-MSCs, and PSCs after treatment with KC and KCM serum
著者:: Sushil Kumar (20371917)
出版事項: (2025) -
Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cells
著者:: Sushil Kumar (20371917)
出版事項: (2025) -
Supplementary Figure 6: Age-dependent differences in CAF activation
著者:: Sushil Kumar (20371917)
出版事項: (2025) -
Supplementary Tables
著者:: Sushil Kumar (20371917)
出版事項: (2025)